and university teacher, I have been convinced that medicine is or ought to be the most humane and most humanistic of all the professions. We are given the privilege of studying our fellow human beings at all stages of life, in all conditions of health and disease (physical, psychological and spiritual) and to see them safely home (at whatever age it may come) on that journey we are all making, the journey towards death. Medicine ought to be, I said, the most humane of all the professions. It very often is. After listening to Dame Cicely Saunders, Medical Director of St Christopher's Hospital, London, in a previous session, my faith in the good practice of the art and science of medicine was fully reactivated. One needs such demonstrations from time to time, because it is sadly true that much of current medical practice is less than humane, and at times borders on the inhumane. The 'organised' medical profession, as represented by its local and national official bodies, seems often unaware of, or uncaring about, the sometimes flagrant breaches of ethics or the law that may be perpetrated by its members. Years ago I observed, in print, (i) that organised medicine represents the most powerful trade union in the world. Like all trade unions, its principal concern appears very often to be the economic well-being of its members and the maintenance or improvement of what it conceives to be the appropriate social status of the profession. There are many signs that this policy, pursued over many decades, has now become or is becoming counterproductive. The profession has good reason to feel fearful for its future.
If medicine is, or ought to be, the most humane of the professions, the law is the most important, the most fundamental, one for society. The law is concemed to establish and maintain the principles of justice, without which a good society cannot function. Society only because of the political 'hoo-ha', and the publicity that it generated, that the cases of Guillain-Barr6 syndrome (always a risk with any vaccine) came to light. Government involvement required that it pay the consequencesit has done so to the tune of many millions of dollars in compensation to real and imagined victims of Guillain-Barr6 disease. The Government didn't pay, of course; the American taxpayer paid. In future circumstances (and who can doubt that now that a precedent is set all future instances of Guillain-Barr6 syndrome will be pursued with vigour by that cadre of lawyers the ranks of which are swelling every year in the US!) it will be the pharmaceutical company that has to pay up, at highly inflated rates, for what is often a very mild disturbance of physical well-being. What company will risk the marketing of a new vaccine no matter how good the research and clinical trials have proved it to be?
The same is true with new drugs, which represent much the largest component in the field of experimental medicine. The use of diethylstilbestrol for prevention of abortion or threatened miscarriage, is a case in point. In the I940S it was confidently regarded as being entirely safe. True, by the late 50s it was realised that there were health problems associated with it. But it was not until the I970S that increased vaginal and cervical cancer came to light in the daughters of women who had had the drug during the embryogenesis of their offspring. Serious defects in the genitourinary tracts of males are now being observed some 20-30 years after exposure to the drug. Now normally, in order to bring a successful prosecution, one has to identify the specific product and its manufacturer. Thirty years ago there were some forty firms distributing DES in the US. In early March the California Supreme Court gave permission to two women victims, who could not specify the particular brand that their mothers had taken, to bring an action against all forty companies. If damages are awarded the companies will be required to contribute in proportion to their share of the market at the relevant time.
It may be that we are a drug-obsessed community. It may be that there are too many firms making too many drugs with potential for harm to the patient. Maybe their activities should be curtailed for the common good. Whether the profits they make are good or bad for society I leave to the economists and politicians to judge in the full knowledge that there will be deep differences of opinion.
Let us look at a few more recent and currently relevant problems: KIDNEY TRANSPLANTATION This initially was a highly experimental procedure with a very low success rate. Renee Fox An experimental procedure which worries me right now is one that is becoming so common that it might be thought to be routine. I refer to the use of ultrasound as a non-invasive technique for the detection by echo of abnormalities within the interior of the body. It is especially valuable for diagnosis of fetal abnormalities, and is regarded as so safe that it is done routinely (and very effectively) prior to amniocentesis. Now it is true that this is non-ionising radiation. But it involves at least some heat-dispersion at the organic interfaces from which the echos bounce back. Scientific reports of damage to cells in tissue-culture when exposed to ultrasound tend to be discounted because the sources used have been powerful ones, and the layer of cells is so thin in culture.
And yet we thought the same about the safety of X-rays in the early days. X-ray damage takes a while to show itself. How do we know that the delicate, growing tissues of embryos and fetuses might not suffer damage (as they clearly did with diethylstilbestrol) which will not manifest itself for many years? The clinical procedure is in full swing and growing rapidly. To my mind much more testing should be done on fetuses of other species whose natural life-span is short to see if exposure in fetuses produces sickness in the adult phase of life.
Scientific research and development in medicine followed the discovery that by the use of penicillin an actual disease could actually be cured by medication. Since then the pharmaceutical industry has had financial motivation for the production of any and all potentially effective drugs. Free market economy clearly produces conflicts of interest which may and often do produce harm for patients. After the success of the Russian sputnik, American pride led to a vast outpouring of funds through NASA and HEW for scientific research and development. It was thought that if we could put a man on the moon we could do anything. Little did the politicians know about the relative simplicity of the science of physics and the enormous complexity of the science of human biology. We were going to 'lick' heart disease, stroke and cancer; we are still trying, with only some modest successes. Now a word about the reasons for society's currently increasing concern that has led to increasing legislative constraints on further scientific advance.
First is the fact that co tment to objective, quantifiable science tends to dehumnize practitioners to the point where they may regard the patient as an experimental creature, the researchers' so-called 'animal of necessity'. Secondly, there is the inevitable competitiveness within the scientific community: competitiveness for grants and promotions and the utimate goal of a Nobel Prize. While Nobel Prizes for Literature and Peace surely do no harm, I am suspicious, for instance, of those in Economics, a discipline which represents an unholy alliance between academia and politics. Prizes for Science and Medicine, though, have produced the most seriously harmful results in terms of vicious competition for advancement, not infrequently leading to secrecy, cheating and theft. I hesitate to think what future historians will make of all this.
Thirdly, it is government funds that have largely supported biomedical science. Such funds are essentially political and subject to all the vagaries of political opinion. When a public scandal emerges, such as the Tuskegee experiments where chronic syphilitics were untreated to serve as an experimental control group, political reaction is swift and ruthless. (5, 6) Fourthly, the Medical-Scientific-Industrial complex has not yet put its ethical house in order. There are too many conflicts of interest to permit the regular practice of a sound medical deontology.
As a result of all these four factors we now see increasing controls over, and bureaucratisation of, biomedical research. In the past, physicians have demanded the right to self-determination for all their activities, but in turn have been very paternalistic -or parentalistic as I prefer to say -towards their patients. Now, it is society's turn to be parentalistic, through regulation and control, towards physicians and biomedical scientists. Patients used to expect to be treated like children, and they seemed to like to be passive and dependent.
Patients are always, of course, ambivalent in their feelings toward parentalistic physicians. John Owen, the i6th century writer, composed an epigram which sums it up:
God and the doctor we alike adore, But only when in danger, not before. The danger o'er, both are alike requited: God is forgotten, and the doctor slighted. We are now in a phase of backlash where the older, passive role of patients is concerned. There is an increasing rejection of parentalism by our patients. Especially is this true in California, that crucible of human evolution where everything is tried until it is found wanting. The movement of patients towards self-help and 'holistic' medicine is very striking. We, in medicine, must readjust towards self-deterniination on the part of our patients. Some of us will find it difficult, but it must be done if we are to survive.
There is an urgent need for a thorough evaluation of professional ethics in medicine. The study must be truly transdisciplinary, because simple interdisciplinary contact between medicine and law leaves each discipline more or less where it was; more heat than light tends to be generated in interdisciplinary studies, especially when they are conducted on an adversarial basis. The medical problem is really a societal one, involving people as persons at all levels. To become again the most humane and most humanistic of the professions we must, in medicine, reawaken concern for human values -which of course include scientific values.
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Switzerland. We drew up and published (7) suggested modifications to the Helsinki Code, some of which were incorporated into the I975 Tokyo revision. A whole new section was added, but this was ignored in Tokyo. This section concerned the need to educate medical students and practitioners concerning human values and human rights. I am glad to see that this present conference will devote its last day to this topic. We also suggested, at Bossey, that the promulgation and implementation of guidelines concerning human experimentation would obviate the need for extensive legislation. I wish that action had been taken on that wise suggestion.
Ultimately our theme in this session requires the development of a satisfying theory of philosophical anthropology, equally acceptable to all, of whatever religious persuasion or none. For more than a hundred years the concepts of evolution in general, and of man in particular, have been seriously misinterpreted by society. We still seem to believe, as Tennyson said before Darwin, that Nature is 'red in tooth and claw'. The phrase 'survival of the fittest' has been seriously misinterpreted to mean 'survival of the strongest or the most aggressive'. The idea that evolution is random and meaningless, in light of the Igth century physical law ofincreasing entropy, has led to much of the nihilism and pessimism of our present age. If the I96os represented the Decade of the Naked Ape and his Territorial Imperative, it is not surprising that the phrase 'the weakest go to the wall' represents the dominant current theory of appropriate human behaviour. Far from being human it is anti-human. It is also anti-evolutionary when we look at evolution properly.
In two recent papers (8, 9 ) I have tried to examine evolution properly, particularly from the point of an attempted development of an evolutionary ethic that can satisfy the deepest longings of all mankind for peace and justice and human rights. We need to see 'Teilhard's Law' which he called the law of 'increasing complexity-consciousness in evolution' (io) as the basis for development of a hopeful dynamism to replace the passive despair of much of the last half century.
It is incumbent on all academics of good will to research, write and teach on these themes. When mankind (including physicians, scientists and lawyers) begins to act according to the golden rule of all philosophies, namely 'do unto others as you would have them do unto you,' then the need for stringent regulations governing human experimentation will become redundant; they will quietly disappear.
